Journal
JOURNAL OF GENERAL VIROLOGY
Volume 94, Issue -, Pages 2771-2776Publisher
MICROBIOLOGY SOC
DOI: 10.1099/vir.0.057299-0
Keywords
-
Categories
Funding
- [SAF-2008-02036]
- [Red de Sida RD12/0017/0038]
Ask authors/readers for more resources
Here we describe the design and strength of a new synthetic late-early optimized (LEO) vaccinia virus (VACV) promoter used as a transcriptional regulator of GFP expression during modified vaccinia Ankara infection. In contrast to the described synthetic VACV promoter (pS), LEO induced significantly higher levels of GFP expression in vitro within the first hour after infection, which correlated with an enhancement in the GFP-specific CD8 T-cell response detected in vivo, demonstrating its potential use in future vaccines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available